Multicenter, Prospective, Rand, PK Study of LCP-Tacro™ Compared to Prograf® Capsules in De Novo Adult Kidney Transplant

NCT01666951 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Failure

Interventions

DRUG: LCP-Tacro tablets
DRUG: Prograf

Sponsor

Veloxis Pharmaceuticals